一项多中心对抗抑郁药在中国COVID前和后的门诊中使用抗抑郁药的回顾性研究
Mengqiang Zhao1,2, Luyao Chang1, Jing Yu1,2
1Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
International journal of clinical pharmacy
|August 14, 2024
概括
在COVID-19后,抗抑郁药的处方在中国显著增加,患者增加了37.1%,处方增加了88.3%. 这一趋势凸显了疫情的流行.
科学领域:
- 精神病学是一个精神病学.
- 流行病学 流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 现实世界的抗抑郁药处方数据为临床医生和政策制定者提供了关键的见解.
- 了解处方模式对于有效的心理健康管理至关重要.
研究的目的:
- 分析中国抗抑郁药处方的现状和趋势.
- 检查从2017年7月到2022年6月的处方模式,包括COVID-19大流行.
主要方法:
- 一项回顾性研究分析了三家医院124,355名患者的数据.
- 处方数据是在COVID-19发病前和后 (每年2.5年) 收集的.
- 基平方测试用于按年龄和性别分层分析.
主要成果:
- 在COVID-19后观察到患者 (37.1%) 和处方 (88.3%) 的显著增加.
- 塞特拉林,西塔洛普拉姆和埃斯基塔洛普拉姆在不同年龄组中经常被处方.
- 具体的药物偏好因年龄和性别而异,单疗法是最常见的 (76.6%).
结论:
- 抗抑郁药的使用在过去五年中呈上升趋势,受到COVID-19大流行病的重大影响.
- 监测这些处方变化有助于评估遵守国家心理健康指南.
更多相关视频
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
480
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
632
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
339
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
339